Key result
Recombinant growth hormone for idiopathic short stature in children and adolescents is discussed in this commentary on a Cochrane review, with no quantitative results reported.
No quantitative synthesis on rhGH for idiopathic short stature; leaves open its clinical role pending updated evidence.
This is a commentary on a Cochrane review, published in this issue of EBCH, first published as: Bryant J, Baxter L, Cave CB, Milne R. Recombinant growth hormone for idiopathic short stature in children and adolescents. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD004440. DOI: 10.1002/14651858.CD004440.pub2 Further information for this Cochrane review is available in this issue of EBCH in the accompanying EBCH Summary and Characteristics and Key Findings Tables articles.
No takes yet. Share an insight, caveat, or question.
Trotsenburg et al. (2008) conducted an editorial in idiopathic short stature. Recombinant growth hormone was evaluated. Recombinant growth hormone for idiopathic short stature in children and adolescents is discussed in this commentary on a Cochrane review, with no quantitative results reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: